Mouwasat Medical Services Company
4002.SR
#2770
Rank
NZ$8.37 B
Marketcap
$41.86
Share price
-0.74%
Change (1 day)
-13.99%
Change (1 year)

P/E ratio for Mouwasat Medical Services Company (4002.SR)

P/E ratio as of November 2024 (TTM): 30.0

According to Mouwasat Medical Services Company's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 29.9918. At the end of 2022 the company had a P/E ratio of 34.9.

P/E ratio history for Mouwasat Medical Services Company from 2012 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202234.916.23%
202130.115.05%
202026.124.74%
201921.0-6.3%
201822.4-0.45%
201722.5-23.05%
201629.20.18%
201529.112.8%
201425.812.6%
201322.948.97%
201215.4

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.